Journal
ONCOGENE
Volume 36, Issue 33, Pages 4767-4777Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2017.80
Keywords
-
Funding
- American Cancer Society [RSG-14-218-01-TBG]
- Prostate Cancer Foundation
- Conquer Cancer Foundation of the American Society of Clinical Oncology [SPORE P50CA58183]
- Pilot/Feasibility Program of the Diabetes and Endocrinology Research Center at Baylor College of Medicine [P30-DK079638]
- CPRIT [RP170295, RP170005, RP150578]
- NIH [R01CA190378, 5T32CA174647-03, DK56338, CA125123]
- NICHD [8818]
- Department of Defense Breast Cancer Research Program Innovator Award
- John S Dunn Gulf Coast Consortium for Chemical Genomics (NCI Cancer Center Support Grant) [P30CA125123]
- Dan L Duncan Cancer Center (NCI Cancer Center Support) [P30CA125123]
- Alkek Foundation for Molecular Discovery Pilot grant
Ask authors/readers for more resources
The E3 ubiquitin ligase adaptor speckle-type POZ protein (SPOP) is frequently dysregulated in prostate adenocarcinoma (PC), via either somatic mutations or mRNA downregulation, suggesting an important tumour suppressor function. To examine its physiologic role in the prostate epithelium in vivo, we generated mice with prostate-specific biallelic ablation of Spop. These mice exhibited increased prostate mass, prostate epithelial cell proliferation, and expression of c-MYC protein compared to littermate controls, and eventually developed prostatic intraepithelial neoplasia (PIN). We found that SPOPWT can physically interact with c-MYC protein and, upon exogenous expression in vitro, can promote c-MYC ubiquitination and degradation. This effect was attenuated in PC cells by introducing PC-associated SPOP mutants or upon knockdown of SPOP via short-hairpin-RNA, suggesting that SPOP inactivation directly increases c-MYC protein levels. Gene Set Enrichment Analysis revealed enrichment of Myc-induced genes in transcriptomic signatures associated with SPOPMT. Likewise, we observed strong inverse correlation between c-MYC activity and SPOP mRNA levels in two independent PC patient cohorts. The core SPOPMT; MYCHigh transcriptomic response, defined by the overlap between the SPOPMT and c-MYC transcriptomic programmes, was also associated with inferior clinical outcome in human PCs. Finally, the organoid-forming capacity of Spop-null murine prostate cells was more sensitive to c-MYC inhibition than that of Spop-WT cells, suggesting that c-MYC upregulation functionally contributes to the proliferative phenotype of Spop knockout prostates. Taken together, our data highlight SPOP as an important regulator of luminal epithelial cell proliferation and c-MYC expression in prostate physiology, identify c-MYC as a novel bona fide SPOP substrate, and help explain the frequent inactivation of SPOP in human PC. We propose SPOPMT-induced stabilization of c-MYC protein as a novel mechanism that can increase total c-MYC levels in PC cells, in addition to amplification of c-MYC locus.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available